[Pharmacological studies on sufoxazine (Y-8894). (I) Effects on experimental amnesia in mice].
The effects of sufoxazine on various experimental amnesia models were studied using passive avoidance behavior in mice. Sufoxazine had no influence on learning and memory in intact mice. Sufoxazine, administered either immediately after CO2 exposure or 30 min prior to the acquisition trial, improved CO2 induced amnesia. It also improved both electroconvulsive shock (ECS) induced amnesia (administered immediately after the amnestic treatment) and scopolamine induced amnesia (administered immediately after the acquisition trial). The anti-depressant drugs, imipramine and desipramine had no ameliorative activity in any of these experimental amnesia models. These results suggest that sufoxazine improves amnesia experimentally induced by various methods.
Anami
K
K
Yamamoto
Y
Y
Setoguchi
M
M
D000647:Amnesia / Q000188:drug therapy* / Q000209:etiology; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects; D002245:Carbon Dioxide; D000697:Central Nervous System Stimulants; D003891:Desipramine / Q000627:therapeutic use; D004597:Electroshock; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D051379:Mice; D009025:Morpholines / Q000494:pharmacology / Q000627:therapeutic use*; D012601:Scopolamine
D000697:Central Nervous System Stimulants; D009025:Morpholines; D002245:Carbon Dioxide; C045330:sufoxazine; D012601:Scopolamine; D007099:Imipramine; D003891:Desipramine